A proposal of a new nomogram for predicting upstaging in contemporary D’Amico low-risk prostate cancer patients

SR Leyh-Bannurah, Paolo Dell’Oglio, Z Tian, J Schiffmann, SF Shariat, N Suardi, F Montorsi, A Briganti, H Heinzer, H Huland, M Graefen, L Budäus, PI Karakiewicz

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: Unfavorable prostate cancer (PCa) disease at final pathology affects at least 10 % of D’Amico low-risk patients. Thus, conservative therapies including active surveillance may be wrongfully applied. The purposes were to assess the rate of upstaging in a contemporary cohort of D’Amico low-risk PCa patients and to develop and externally validate a nomogram as upstaging prediction tool in two European cohorts. Methods: Analyses were restricted to 2007 patients who harbored low-risk PCa at ≥10-cores initial biopsy according to D’Amico classification (PSA
Original languageEnglish
Pages (from-to)189-197
Number of pages9
JournalWorld Journal of Urology
Volume35
Issue number2
DOIs
Publication statusPublished - 2017

Fingerprint

Dive into the research topics of 'A proposal of a new nomogram for predicting upstaging in contemporary D’Amico low-risk prostate cancer patients'. Together they form a unique fingerprint.

Cite this